| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |